The Cannabis Investing Podcast · Seeking Alpha

Cannabis investing in the Trump era

·54 min·2 clips
The episode starts with a live reaction to Trump’s executive order and the renewed attention around cannabis stocks. Rina Sherbel brings in Jerry Deriviani and Josh Rosen. Rosen talks through his background at Bengal Capital and his operating role with Grown Rogue. The conversation then turns to what actually changes when the market starts talking again. The speakers do not treat headline interest as proof of a lasting shift. They keep returning to operating integrity as a real differentiator. Capital allocation also comes up as something that can make or break companies in this industry. Forefront is used as a cautionary example. Massachusetts and Illinois show that good operations can help in a competitive market, but only to a point. The balance sheet still matters most when financing windows are tight. Heavy bets in California are described as part of the problem. Delays on a large Illinois facility are framed the same way. The result is a blunt lesson about how quickly weak financial discipline can undo operational progress. The conversation connects that lesson to the broader wave of insolvencies in the last 18 to 24 months. The tone stays analytical, not celebratory. When the talk shifts to leadership and governance, it stays on the personal lessons that come from managing through failure. Rosen describes those experiences as scar tissue that shaped later decisions. That history is part of the blueprint for preserving value at Vireo. The hosts then widen the frame and ask whether first-mover advantage really exists in cannabis. The answer is treated as conditional, not absolute. Early entry can help with market access and customer penetration. But that edge still has to survive competitive pressure, regulation, debt, and timing. The episode closes where it starts. Policy may create interest, but investors still need to look past the noise. The real question is whether the businesses underneath can endure long enough for any catalyst to matter.

As heard by us

Policy noise meets balance-sheet reality.

Trump's executive-order moment gives the conversation a timely frame, but the episode keeps its attention on the harder question of what actually matters for cannabis operators.

Read the full review in PlayNext →

Why you'd press play

You want the Trump executive order filtered through actual cannabis market reality.

Read the full recommendation in PlayNext →
Listen to the show on